title: Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
authors.affiliation: Cardiac Catheterization Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Orford
authors.forename: S
authors.initials: S
authors.lastname: Kinlay
authors.forename: J
authors.initials: J
authors.lastname: Fernandes
authors.forename: D
authors.initials: D
authors.lastname: Behrendt
authors.forename: P
authors.initials: P
authors.lastname: Ganz
authors.forename: A P
authors.initials: AP
authors.lastname: Selwyn
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006946:Hyperinsulinism / Q000150:complications; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications; D007333:Insulin Resistance; D012307:Risk Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007004:Hypoglycemic Agents